These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9404530)

  • 1. [Depression in advanced age. Response and tolerance speak for SSRI].
    Nervenarzt; 1996 Aug; 67(8 Suppl Depression):1-4. PubMed ID: 9404530
    [No Abstract]   [Full Text] [Related]  

  • 2. On the therapeutic action of SSRI medications.
    Wolpert E
    J Am Psychoanal Assoc; 2004; 52(2):489; author reply 493-8. PubMed ID: 15222455
    [No Abstract]   [Full Text] [Related]  

  • 3. On the therapeutic action of SSRI medications.
    Ostow M
    J Am Psychoanal Assoc; 2004; 52(2):486-9; author reply 493-8. PubMed ID: 15222454
    [No Abstract]   [Full Text] [Related]  

  • 4. On the therapeutic action of SSRI medications.
    Levine FJ
    J Am Psychoanal Assoc; 2004; 52(2):492-3; author reply 493-8. PubMed ID: 15222457
    [No Abstract]   [Full Text] [Related]  

  • 5. Should industry speak the loudest in informing the public on medical matters?
    McCarter G
    PLoS Med; 2006 Feb; 3(2):e118; author reply e116. PubMed ID: 16492082
    [No Abstract]   [Full Text] [Related]  

  • 6. On the therapeutic action of SSRI medications.
    Sandberg LS
    J Am Psychoanal Assoc; 2004; 52(2):490-1; author reply 493-8. PubMed ID: 15222456
    [No Abstract]   [Full Text] [Related]  

  • 7. On the therapeutic action of SSRI medications.
    Levinson MH
    J Am Psychoanal Assoc; 2004; 52(2):483-6; author reply 493-8. PubMed ID: 15222453
    [No Abstract]   [Full Text] [Related]  

  • 8. Why did the FDA approve these advertisements?
    Oaks D
    PLoS Med; 2006 Feb; 3(2):e117; author reply e116. PubMed ID: 16492081
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple serotonergic paths to antidepressant efficacy.
    Lutz PE
    J Neurophysiol; 2013 May; 109(9):2245-9. PubMed ID: 23343901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology Update: The Selective Serotonin Reuptake Inhibitors.
    Lorman WJ
    J Addict Nurs; 2018; 29(4):260-261. PubMed ID: 30507822
    [No Abstract]   [Full Text] [Related]  

  • 11. Depression: more than just serotonin.
    Secko D
    CMAJ; 2005 Jun; 172(12):1551. PubMed ID: 15939910
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.
    Kendrick T; Chatwin J; Dowrick C; Tylee A; Morriss R; Peveler R; Leese M; McCrone P; Harris T; Moore M; Byng R; Brown G; Barthel S; Mander H; Ring A; Kelly V; Wallace V; Gabbay M; Craig T; Mann A
    Health Technol Assess; 2009 Apr; 13(22):iii-iv, ix-xi, 1-159. PubMed ID: 19401066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationship of selective serotonin reuptake inhibitors.
    Dold M; Kasper S
    Acta Psychiatr Scand; 2020 Dec; 142(6):427-429. PubMed ID: 33315261
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors.
    Lippincott Health Promot Lett; 1997; 2(10):5. PubMed ID: 9407834
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinician compliance to recommendations regarding the risk of suicidality with selective serotonin reuptake inhibitors in the treatment of children and adolescents.
    Sørensen JØ; Rasmussen A; Roesbjerg T; Pagsberg AK
    Eur Child Adolesc Psychiatry; 2020 May; 29(5):707-718. PubMed ID: 31701374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Apathy syndrome in depressed patients previously treated with selective serotonin reuptake inhibitors].
    Petrova NN; Markin AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(1):111-117. PubMed ID: 32105278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New perspectives in the serotoninergic treatment for depression].
    Hamon M
    Therapie; 1995; 50(6):505-9. PubMed ID: 8745948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective serotonin reuptake inhibitor treatment and depression are associated with poststroke mortality.
    Ried LD; Jia H; Feng H; Cameon R; Wang X; Tueth M; Wu SS
    Ann Pharmacother; 2011 Jul; 45(7-8):888-97. PubMed ID: 21750310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
    Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
    JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of selective serotonin reuptake inhibitor (SSRI) in the treatment of depression].
    Semba J
    Nihon Yakurigaku Zasshi; 2000 Aug; 116(2):79-84. PubMed ID: 10976459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.